These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39090045)

  • 1. Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea.
    Maloney N; Novoa R; Yeh JE
    Dermatol Online J; 2024 Jun; 30(3):. PubMed ID: 39090045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxycarbamide-induced cutaneous ulceration with a difference.
    Matthews AG; Wylie G
    Br J Dermatol; 2014 Dec; 171(6):1572-4. PubMed ID: 24888252
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
    Reilly JT
    Eur J Haematol Suppl; 2007 Oct; (68):32-4. PubMed ID: 17727564
    [No Abstract]   [Full Text] [Related]  

  • 4. Leg ulcers and hydroxyurea: report of three cases with essential thrombocythemia.
    Demirçay Z; Cömert A; Adigüzel C
    Int J Dermatol; 2002 Dec; 41(12):872-4. PubMed ID: 12492973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
    Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated superficial porokeratosis and pyoderma gangrenosum.
    di Meo N; Fluehler C; Perkan V; Trevisan G
    Dermatol Online J; 2010 Oct; 16(10):15. PubMed ID: 21062609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea-induced leg ulceration in a patient with a homozygous MTHFR polymorphism misdiagnosed as pyoderma gangrenosum.
    Crittenden SC; Gilbert JE; Callen JP
    JAMA Dermatol; 2014 Jul; 150(7):780-1. PubMed ID: 24599173
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyoderma gangrenosum of the upper eyelid.
    Bromeo AJ; Suller A
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31289150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum in a patient with essential thrombocythemia.
    King KW; Murray A
    J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple, painful, treatment-resistant leg ulcers associated with dermatomyositis-like lesions over the interphalangeal joints induced by hydroxyurea].
    Martorell-Calatayud A; Requena C; Nagore-Enguídanos E; Guillén-Barona C
    Actas Dermosifiliogr; 2009 Nov; 100(9):804-7. PubMed ID: 19889302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial granulomatous pyoderma: an idiopathic granulomatous cutaneous ulceration.
    Thami GP; Kaur S; Punia RS; Kanwart AJ
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):159-61. PubMed ID: 12046823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyoderma gangrenosum in a patient with collagenous colitis.
    Batra AK; Levey JM; Trister J; Patwardhan R
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S277-9. PubMed ID: 14576653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pyoderma gangrenosum, an etiology of chronic ulcer disregarded?].
    Zaugg P; Koch N; Erba P; Raffoul W
    Rev Med Suisse; 2016 Feb; 12(505):318-21. PubMed ID: 27039446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cutaneous lesions secondary to hydroxyurea therapy.
    Radaelli F; Calori R; Faccini P; Maiolo AT
    Am J Hematol; 1998 May; 58(1):82-3. PubMed ID: 9590156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermotropism of inflammatory cells differentiates pyoderma gangrenosum from venous leg ulcers.
    Ronicke M; Baur A; Kirr M; Erdmann M; Erfurt-Berge C; Ostalecki C
    J Dtsch Dermatol Ges; 2022 May; 20(5):619-627. PubMed ID: 35487858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ulceration of the scalp: a unique manifestation of pyoderma gangrenosum].
    Poenitz N; Tadler D; Klemke CD; Glorer E; Goerdt S
    J Dtsch Dermatol Ges; 2005 Feb; 3(2):113-6. PubMed ID: 16351014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
    Duarte AF; Nogueira A; Lisboa C; Azevedo F
    Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycosis fungoides presenting with extensive pyoderma gangrenosum-like ulcers.
    Carbia SG; Hochman A; Chaín M; Dei-Cas I; Lagodín C; Devés A; Woscoff A
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):401-4. PubMed ID: 12224703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Becaplermin for nondiabetic ulcers: pyoderma gangrenosum and calciphylaxis.
    Twu O; Mednik S; Scumpia P; Doaty S; Worswick S
    Dermatol Ther; 2016; 29(2):104-8. PubMed ID: 26556220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread vegetating ulcers.
    Tull TJ; Calonje E; Wain EM
    Clin Exp Dermatol; 2019 Jul; 44(5):553-555. PubMed ID: 30259553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.